# Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)

> **NCT04979806** · PHASE3 · COMPLETED · sponsor: **Wockhardt** · enrollment: 530 (actual)

## Conditions studied

- Complicated Urinary Tract Infection
- Acute Pyelonephritis

## Interventions

- **DRUG:** Cefepime-zidebactam (FEP-ZID)
- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT04979806
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-28
- **Primary completion:** 2024-11-25
- **Final completion:** 2024-11-25
- **Target enrollment:** 530 (ACTUAL)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979806, "Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04979806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*